Home › Compare › ROSSF vs JNJ

ROSSF vs JNJ: Dividend Comparison 2026

ROSSF yields 40000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ROSSF wins by $5.18024517379999e+22M in total portfolio value
10 years
ROSSF
ROSSF
● Live price
40000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.18024517379999e+22M
Annual income
$51,548,940,318,215,365,000,000,000,000.00
Full ROSSF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ROSSF vs JNJ

📍 ROSSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodROSSFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ROSSF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ROSSF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ROSSF
Annual income on $10K today (after 15% tax)
$3,400,000.00/yr
After 10yr DRIP, annual income (after tax)
$43,816,599,270,483,060,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ROSSF beats the other by $43,816,599,270,483,060,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ROSSF + JNJ for your $10,000?

ROSSF: 50%JNJ: 50%
100% JNJ50/50100% ROSSF
Portfolio after 10yr
$2.590122586899995e+22M
Annual income
$25,774,470,159,107,683,000,000,000,000.00/yr
Blended yield
99.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ROSSF
No analyst data
Altman Z
-496.9
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ROSSF buys
0
JNJ buys
0
No recent congressional trades found for ROSSF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricROSSFJNJ
Forward yield40000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$5.18024517379999e+22M$20.0K ✓
Annual income after 10y$51,548,940,318,215,365,000,000,000,000.00 ✓$827.78
Total dividends collected$5.178579568047658e+22M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ROSSF vs JNJ ($10,000, DRIP)

YearROSSF PortfolioROSSF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$4,010,700$4,000,000.00$10,676$355.77+$4.00M → ROSSF
2$1,503,618,552$1,499,327,102.80$11,407$389.39+$1503.61M → ROSSF
3$526,936,342,129$525,327,470,278.19$12,198$426.53+$526936.33M → ROSSF
4$172,618,628,820,566$172,054,806,934,488.28$13,056$467.62+$172618628.81M → ROSSF
5$52,860,672,107,805,460$52,675,970,174,967,450.00$13,987$513.12+$52860672107.79M → ROSSF
6$15,132,132,379,588,594,000$15,075,571,460,433,242,000.00$14,998$563.56+$15132132379588.58M → ROSSF
7$4,049,462,878,006,525,600,000$4,033,271,496,360,366,000,000.00$16,098$619.52+$4049462878006525.50M → ROSSF
8$1,013,053,710,099,385,500,000,000$1,008,720,784,819,918,400,000,000.00$17,295$681.69+$1013053710099385472.00M → ROSSF
9$236,926,560,546,299,530,000,000,000$235,842,593,076,493,200,000,000,000.00$18,599$750.82+$236926560546299510784.00M → ROSSF
10$51,802,451,737,999,890,000,000,000,000$51,548,940,318,215,365,000,000,000,000.00$20,022$827.78+$5.18024517379999e+22M → ROSSF

ROSSF vs JNJ: Complete Analysis 2026

ROSSF — Stock

Ross Group Plc, through its subsidiaries, provides supply chain management services. The company was incorporated in 1913 and is based in London, the United Kingdom.

Full ROSSF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ROSSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ROSSF vs SCHDROSSF vs JEPIROSSF vs OROSSF vs KOROSSF vs MAINROSSF vs ABBVROSSF vs MRKROSSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.